Eris Lifesciences Limited

Corporate

Verify this issuer →
Methodology v1.0 Download Report (PDF)
Latest Rating
AA- (INDIA_RATINGS)
Total Debt Outstanding
₹1,250 Cr
Across 2 instruments
Listed Bonds
2
First Issue
2024-06-07
Latest Issue
2024-06-07
Maturity Range
2026 - 2027
Observation
2 active bonds tracked from this issuer.
View details →
Coverage: Medium Data Quality: Medium Sources: NSE, BSE, SEBI, rating agencies
01 Issuer Overview
Sector
Issuer Type
Corporate
First Tracked Bond
2024-06-07
Start of this issuer's debt program timeline
  • 2 active bonds tracked from this issuer.
  • 0 of 2 tracked bonds with a stated security status are secured. (based on 2 bonds with a disclosed security status)

Operating in India, Eris Lifesciences Limited is classified as a corporate issuer. Bond coupons here span 8.73% - 8.73%, paid annual. The maturity ladder spans 2026 - 2027.

Data sourced from NSDL, BSE, NSE, and registered credit rating agencies. Verify against the issuer's offer document before transacting.

Thanks — your suggestion has been submitted for review.

02 Debt Profile
Outstanding Bonds
2
Tracked by RetailBonds
Amount Tracked
₹1,250 Cr
Of bonds tracked by RetailBonds — not the issuer's total outstanding debt
Avg Coupon
8.73%
Range 8.73% - 8.73%
Avg Remaining Tenure
0.5 Yrs
Nearest maturity 2026-12
Secured
0%
0 of 2 bonds with known status
Callable
0
Of 2 bonds
Avg Spread vs G-Sec
+302 bps
Credit premium (indicative)

Maturity Profile

Active bonds maturing, by year. Bar height relative to the tallest year (1 bonds).

0 2026: 1 bond, ₹625 Cr tracked, avg coupon 8.73% 1 bond 2026 2027: 1 bond, ₹625 Cr tracked, avg coupon 8.73% 1 bond 2027

Security Type / Instrument Mix

  • NCD 2 bonds · 100% · ₹1,250 Cr tracked

Funding Evolution

■ Issued that year — Cumulative outstanding (tracked)
2024: ₹1,250 Cr issued 2024 Cumulative: ₹1,250 Cr

Based on 2 of 2 active bonds with a known issue date and issue size.

Financial Snapshot

FY26
Revenue from Operations
₹60.63 Cr
 
Profit Before Tax
₹9.56 Cr
 

As filed under SEBI LODR Reg 52(4) / Integrated Filing, filed 7 Jul 2026. Figures are reported facts, not a rating or recommendation.

03 Credit Profile
  • AA 2 bonds · 100%
AgencyRatingOutlookBonds
INDIA_RATINGS AA- 2

Recent Rating Actions

No rating action history available.

04 Outstanding Bonds View all bonds →
ISIN Bond Name Coupon Rating Maturity YTM Last Trade
INE406M08011 8.73% UNSECURED RATED LISTED REDEEMABLE NON-CONVERTIBLE DEBENTURE STRPP I DATE OF MATURITY 07/12/2026 8.73% AA- (INDIA_RATINGS) 2026-12-07
INE406M08029 8.73% UNSECURED RATED LISTED REDEEMABLE NON-CONVERTIBLE DEBENTURE STRPP II DATE OF MATURITY 07/06/2027 8.73% AA- (INDIA_RATINGS) 2027-06-07
Compare (/) Compare Bonds

YTM and Last Trade depend on secondary-market volume — shown only for bonds with a recorded BSE/NSE trade.

05 Market Activity

No recorded secondary-market trades in the last 30 days.

06 Regulatory Filings
07 Methodology & Data Coverage
DatasetCountFreshness
Credit Ratings (current) 2 2024-05-28
Rating Actions History 0
Secondary-Market Trades 0
Reg52(4) Payment Disclosures 0

Methodology version 1.0. See full methodology for sources and limitations.

Related Issuers

All issuers →
Frequently Asked Questions
How many active bonds does Eris Lifesciences Limited have?

Eris Lifesciences Limited currently has 2 active bonds with coupons 8.73% - 8.73%, maturities spanning 2026 - 2027.

What is Eris Lifesciences Limited's credit rating?

The most recent rating on Eris Lifesciences Limited's bonds is AA- (INDIA_RATINGS), published by INDIA_RATINGS.

Are Eris Lifesciences Limited's bonds secured?

Of the 2 bonds with a disclosed security status, 0 are secured (0%) and 2 are unsecured.

When do Eris Lifesciences Limited's bonds mature?

Eris Lifesciences Limited's active bonds mature between 2026 - 2027; the nearest matures in 2026-12; the average tenure is 0.5 Yrs.

What is the average coupon on Eris Lifesciences Limited's bonds?

The average coupon across Eris Lifesciences Limited's 2 active bonds is 8.73%.

Disclaimer: This page aggregates publicly available data about Eris Lifesciences Limited for informational purposes only. Ratings shown are the opinion of the issuing rating agency and are not buy/sell recommendations. RetailBonds.in does not issue its own ratings or investment advice. Verify all data against the issuer’s offer document before transacting.